Merck & Co., Inc. (MRK)
|Net Income (ttm)||15.26B|
|Ex-Dividend Date||Dec 14, 2022|
|Day's Range||108.75 - 111.37|
|52-Week Range||71.97 - 111.37|
|Price Target||112.55 (+3.5%)|
|Earnings Date||Oct 27, 2022|
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions an... [Read more]
In 2021, Merck & Co.'s revenue was $48.70 billion, an increase of 17.31% compared to the previous year's $41.52 billion. Earnings were $13.05 billion, an increase of 84.65%.Financial Statements
According to 32 analysts, the average rating for MRK stock is "Buy." The 12-month stock price forecast is 112.55, which is an increase of 3.47% from the latest price.
Does Merck (MRK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Final Trades: Stryker, Southwest Gas, Freeport-McMoRan & more
The "Halftime Report" traders give their top picks to watch for the second half.
Amid the rising possibility of a recession, defensive stocks with solid prospects will cushion investors from market jitters while their robust fundamentals ensure higher returns. ADM, HSY, UNH and MRK ...
Is it too late to buy these soaring stocks?
Is Merck stock a buy after the company announced its acquisition of Imago, a bone marrow diseases company? Is MRK stock a buy now?
During times of heightened volatility, adding low-beta stocks can help blend in an extra layer of portfolio defense.
We have narrowed our search to four Dow stocks. These are: CAT, WMT, MRK, UNH.
Wondering how to invest in stocks and mutual funds amid a grim market? Red-hot Invesco Comstock Select Fund is doubling down on its strategy.
Merck (MRK) could produce exceptional returns because of its solid growth attributes.
Merck & Co., Inc. (MRK), McCormick & Company, Incorporated (MKC) and Tsakos Energy Navigation Limited (TNP) recently hiked dividends.
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology...
RAHWAY, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from clinical trials and real-world studies at the ...
Amid rising concerns about the state of the global economy, rising inflation, central bank interest rate hikes and increased Covid-19 restrictions in China, marked indexes were mixed on Wednesday morning.
Three-Stock Lunch: PayPal, Merck and Broadcom
Quint Tatro, Joule Financial founder and CEO, joins 'Power Lunch' to discuss his investing take on three stocks: PayPal, Merck and Broadcom.
RAHWAY, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.73 per share...
Throughout the beginning of the Covid-19 pandemic, pharmaceutical companies were mostly focused on the availability and effectiveness of vaccines. However, around December 2021, the focus shifted more t...
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Merck (MRK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
For investors looking for growth, biotech stocks are a great place to start one's search. This is a sector that's seen its valuation multiples decline in many cases to a greater extent than the overall ...
Top-line data from a late-stage study shows that Merck's (MRK) Keytruda combined with chemotherapy improved overall survival in patients with advanced gastric cancer.
IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Ade...
NEW ORLEANS--( BUSINESS WIRE )--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Imago BioScience...
The Dow Jones Industrial Average is down around 6.2% year to date. Of the 30 stocks in the index, 14 are down at least 10% for the year.
We have narrowed our search to five U.S. corporate behemoths that have popped year to date. These are: ADM, MPC, XOM, MRK and MCK.
TOKYO—Japan approved an antiviral pill from Shionogi & Co. to treat Covid-19 after the company provided new data to show the drug's efficacy.
Merck Announces Phase 3 KEYNOTE-859 Trial Met Primary Endpoint of Overall Survival in Patients With HER2-Negative Gas...
RAHWAY, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the pivotal Phase 3 KEYNOTE-859 trial investigatin...